Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
基本信息
- 批准号:8287047
- 负责人:
- 金额:$ 15.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-10 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The primary goal of the Ph.D. Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) in the Mayo Graduate School is the development of independent investigators capable of directing outstanding research Programs in academia, industry or other settings. The faculty is comprised of 28 well- funded, independent investigators, who focus on a continuum of research areas encompassing studies from basic molecular and genetic aspects of disease through drug discovery and development of novel therapies for cardiovascular and malignant diseases. The faculty provides training opportunities in areas that include computational chemistry, molecular mechanisms of drug action and resistance, metabolomics, novel therapeutic strategies, the genetics of addiction, preclinical and clinical pharmacology, and pharmacogenomics of genes associated with drug responses. Twenty-six predoctoral students are currently enrolled in the MPET Ph.D. training program. A rigorous didactic curriculum includes a series of Core Curriculum courses that ensures a strong fundamental knowledge in biochemistry, molecular biology, genetics, statistics, cell biology and pharmacology and a series of tutorial-based courses to provide students with advanced training in molecular pharmacology. During their first two years of study, students complete at least 3 laboratory rotations and select a laboratory for their thesis research. They sit for comprehensive written and oral qualifying examinations at the end of year two. After developing a written thesis proposal delineating the questions and approaches to be pursued in the thesis research, the thesis committee reviews the proposed research at the first committee meeting. Student's present work-in-progress updates on their research projects to MPET faculty and students each year. Students are required to publish completed work in a timely manner and encouraged to attend national meetings to present their work. The average time to completion of the Ph.D. Program is 5.2 years. Starting in Year 3 and beyond, students meet with their thesis committees at least twice per year and are mentored to identify outstanding postdoctoral training opportunities as the next step in their career development. Graduates of the MPET Ph.D. training program have outstanding track records. They go on to postdoctoral fellowships, with many now serving as principal investigators in academia and industry. We request 4 positions for the next funding period.
描述(由申请人提供):博士学位的主要目标。梅奥研究生院的分子药理学和实验治疗学 (MPET) 培训项目旨在培养能够在学术界、工业界或其他环境中指导杰出研究项目的独立研究人员。该学院由 28 名资金充足的独立研究人员组成,他们专注于一系列研究领域,包括从疾病的基本分子和遗传方面的研究到心血管和恶性疾病的药物发现和新疗法的开发。该学院提供的培训机会包括计算化学、药物作用和耐药性的分子机制、代谢组学、新颖的治疗策略、成瘾遗传学、临床前和临床药理学以及与药物反应相关的基因的药物基因组学。目前有 26 名博士前学生正在攻读 MPET 博士学位。培训计划。严格的教学课程包括一系列核心课程,确保学生在生物化学、分子生物学、遗传学、统计学、细胞生物学和药理学方面掌握扎实的基础知识,以及一系列辅导课程,为学生提供分子药理学的高级培训。在学习的前两年中,学生至少完成 3 次实验室轮换,并选择一个实验室进行论文研究。他们在第二年末参加综合笔试和口试资格考试。在制定书面论文提案,描述论文研究中要追求的问题和方法后,论文委员会在第一次委员会会议上审查拟议的研究。学生每年都会向 MPET 教职员工和学生介绍其研究项目的进展情况。要求学生及时发表已完成的作品,并鼓励他们参加全国会议展示他们的作品。完成博士学位的平均时间学制5.2年。从三年级及以后开始,学生每年至少与论文委员会会面两次,并接受指导以确定优秀的博士后培训机会作为他们职业发展的下一步。 MPET 博士毕业生培训计划有出色的记录。他们继续获得博士后奖学金,其中许多人现在担任学术界和工业界的首席研究员。我们为下一个资助期请求 4 个职位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARRY M KARNITZ其他文献
LARRY M KARNITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARRY M KARNITZ', 18)}}的其他基金
Project 3: Repurposing Ceritinib for Ovarian Cancer Therapy
项目 3:重新利用色瑞替尼治疗卵巢癌
- 批准号:
10452721 - 财政年份:2009
- 资助金额:
$ 15.76万 - 项目类别:
Project 3: Repurposing Ceritinib for Ovarian Cancer Therapy
项目 3:重新利用色瑞替尼治疗卵巢癌
- 批准号:
10268765 - 财政年份:2009
- 资助金额:
$ 15.76万 - 项目类别:
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
8677598 - 财政年份:2005
- 资助金额:
$ 15.76万 - 项目类别:
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
8851608 - 财政年份:2005
- 资助金额:
$ 15.76万 - 项目类别:
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
9070065 - 财政年份:2005
- 资助金额:
$ 15.76万 - 项目类别:
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
8494058 - 财政年份:2005
- 资助金额:
$ 15.76万 - 项目类别:
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
8015781 - 财政年份:2005
- 资助金额:
$ 15.76万 - 项目类别:
相似海外基金
National Career Development Program for Researchers in Pediatric Clinical Pharmacology
儿科临床药理学研究人员国家职业发展计划
- 批准号:
11001312 - 财政年份:2024
- 资助金额:
$ 15.76万 - 项目类别:
Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacology
代谢型谷氨酸受体异聚化对信号传导和药理学的影响
- 批准号:
10637938 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别:
Training in Systems Pharmacology and Toxicology (T-SPaT)
系统药理学和毒理学培训 (T-SPaT)
- 批准号:
10714918 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别:
Clinical Pharmacology Quality Assurance (CPQA)
临床药理学质量保证(CPQA)
- 批准号:
10850504 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
- 批准号:
10932479 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别:
Pharmacology Consulting Services in relation to Pharmaceutical Development with Pain expertise. 09/12/2023 - 09/11/2024
与具有疼痛专业知识的药物开发相关的药理学咨询服务。
- 批准号:
10949065 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别:
Fellowship Programs
Understanding the clinical pharmacology of marijuana-tobacco co-administration
了解大麻-烟草联合用药的临床药理学
- 批准号:
10660409 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别:
Learning How to Give Casual Explanations for Large Scale Virtual and Morphological Pharmacology
学习如何对大规模虚拟和形态药理学进行随意解释
- 批准号:
10713386 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别: